Governance Roche Holding AG

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:31:45 10/09/2024 BST			5-day change	1st Jan Change
268.90 ^CHF	+0.64%		-4.51%	+9.98%

06:01pm	ROCHE HOLDINGS AG : UBS remains Neutral	ZD
05:43pm	Roche Opens New Research Center in Switzerland	MT

Executive Committee: Roche Holding AG

Manager

Positions heldSince

Thomas Schinecker

49 year

Chief Executive Officer

14/03/2023

Levi Garraway

Chief Tech/Sci/R&D Officer

Pascale Schmidt

51 year

Compliance Officer

31/12/2019

Claudia Boeckstiegel

60 year

General Counsel

31/03/2020

Annette Luther

54 year

Corporate Secretary

31/03/2020

Alan Hippe

57 year

Chief Tech/Sci/R&D Officer	06/09/2011
Director of Finance/CFO	05/06/2011

Cristina A. Wilbur

57 year

Human Resources Officer

Bruno Eschli

Investor Relations Contact

Composition of the Board of Directors: Roche Holding AG

Director

CommitteesSince

Severin Schwan

57 year

Executive Committee

31/12/2012

André S. Hoffmann

66 year

Governance Committee	31/12/1995
Nominating Committee	31/12/1995
Compensation Committee Chair	07/04/2013
Governance Committee Chair	31/12/1995

Claudia Dyckerhoff

58 year

Governance Committee	29/02/2016
Compensation Committee	20/04/2016

Anita Hauser

55 year

Compensation Committee	31/12/2006
Governance Committee	13/03/2017

Ulf Mark Schneider

59 year

Audit Committee	30/09/2014
Governance Committee	30/09/2014

Bernard Poussot

72 year

Compensation Committee

31/12/2014

Joerg Duschmale

40 year

Audit Committee

16/03/2020

Patrick Frost

56 year

Audit Committee

16/03/2020

Richard P. Lifton

71 year

Director/Board Member	02/03/2015
Independent Dir/Board Member	02/03/2015

Jemilah Mahmood

Director/Board Member

Akiko Iwasaki

Director/Board Member

Latest Appointments: Roche Holding AG

Page Industries Limited Announces Change in Directorate	08-08	CI
JW Therapeutics Co. Ltd Announces CEO Changes	07-31	CI
Zealand Pharma Names Chief Commercial Officer	07-30	MT
Immunic, Inc. Appoints Simona Skerjanec as Member of the Board	07-24	CI
Nkarta, Inc. Appoints George Vratsanos as Board of Directors	06-13	CI
Roche appoints Director of Corporate Business Development	05-27	CF
Roche Announces Management and Board Committee Changes	05-27	CI

More news

Former Officers and Directors: Roche Holding AG

Insider

Positions held

SinceUntil

Christoph Franz

Chairman	28/02/2014	14/03/2023
Independent Dir/Board Member	28/02/2014	14/03/2023

Julie Brown

Director/Board Member	29/02/2016	25/09/2022
Independent Dir/Board Member	29/02/2016	25/09/2022

William Pao

Corporate Officer/Principal

30/04/2014

17/03/2022

Paul Bulcke

Director/Board Member	05/06/2011	31/12/2021
Independent Dir/Board Member	05/09/2011	14/03/2012

Gottlieb A. Keller

General Counsel	12/01/2010	30/03/2020
Corporate Secretary	31/12/2007	30/03/2020

John Bell

Director/Board Member	16/09/2009	16/03/2020
Independent Dir/Board Member	31/03/2011	11/09/2011
Corporate Officer/Principal	31/12/2000	16/09/2009

Andreas Oeri

Director/Board Member	12/01/2010	16/03/2020
Independent Dir/Board Member	05/09/2011	16/03/2020
Corporate Officer/Principal	31/12/1995	12/01/2010

Stephan Feldhaus

Public Communications Contact

07/09/2010

29/09/2019

Peter Voser

Director/Board Member	31/01/2011	29/06/2019
Independent Dir/Board Member	05/09/2011	14/03/2012

John Reed

Corporate Officer/Principal

01/04/2013

01/04/2018

Roland Diggelmann

Corporate Officer/Principal

31/12/2011

31/12/2017

Pius Baschera

Director/Board Member	12/01/2010	30/03/2017
Independent Dir/Board Member	05/09/2011	11/09/2011

DeAnne Shirley Julius

Director/Board Member	12/01/2010	29/02/2016
Independent Dir/Board Member	05/09/2011	29/02/2016
Corporate Officer/Principal	31/12/2001	12/01/2010

Beatrice Weder di Mauro

Director/Board Member	12/01/2010	29/02/2016
Independent Dir/Board Member	28/07/2011	11/09/2011

Silvia Ayyoubi

Human Resources Officer

12/01/2010

30/12/2015

Hyam Levitsky

Corporate Officer/Principal

31/07/2011

31/01/2015

Michael Varney

Corporate Officer/Principal

31/12/2014

Richard Scheller

Corporate Officer/Principal

31/12/2008

30/12/2014

William Burns

Director/Board Member	28/02/2010	03/03/2014
Independent Dir/Board Member	28/02/2010	14/03/2012

Franz Humer

Chairman

05/09/2011

03/03/2014

Bruno Gehrig

Director/Board Member	31/12/2003	04/03/2013
Independent Dir/Board Member	31/12/2003	14/03/2012

Lodewijk J. R. de Vink

Director/Board Member	12/01/2010	04/03/2013
Independent Dir/Board Member	10/04/2011	11/09/2011
Corporate Officer/Principal	31/12/2003	12/01/2010

Jean-Jacques Garaud

Corporate Officer/Principal

31/12/2006

29/06/2012

Klaus Gustav Strein

Corporate Officer/Principal

13/09/2011

Erich Hunziker

Director/Board Member	17/01/2011	17/01/2011
Chief Tech/Sci/R&D Officer	12/01/2010	30/03/2011
Director of Finance/CFO	30/09/2001	30/03/2011

Wolfgang Ruttenstorfer

Director/Board Member	12/01/2010	13/12/2010
Independent Dir/Board Member	31/12/2006	31/12/2010

Walter Frey

Director/Board Member	12/01/2010	13/12/2010
Independent Dir/Board Member	31/12/2000	31/12/2010
Corporate Officer/Principal	31/12/2000	12/01/2010

David M. Goldstein

Corporate Officer/Principal

31/12/1993

31/12/2010

Peter Brabeck-Letmathe

Director/Board Member

28/02/2010

Arthur Levinson

Director/Board Member	28/02/2010	-
Independent Dir/Board Member	25/04/2011	11/09/2011

Per-Olof Attinger

Corporate Officer/Principal

31/12/2009

Eduard Enrico Holdener

Corporate Officer/Principal

31/12/1994

31/12/2006

Michael Burgess

Corporate Officer/Principal

23/10/2011

Rolf Hänggi

Director/Board Member

31/12/2005

Dirk W. Kirsten

Corporate Officer/Principal

31/12/2001

31/12/2003

Domenico Scala

Corporate Officer/Principal	31/12/1994	31/12/1999
Treasurer	31/12/1999	31/12/2002

Henri-Paul Meier

Investor Relations Contact	08/09/2011	-
Public Communications Contact	14/03/2002	-

Horst Teltschik

Director/Board Member	12/01/2010	-
Corporate Officer/Principal	31/12/2001	12/01/2010

Anton Affentranger

Director of Finance/CFO

Jürg Witmer

Public Communications Contact

31/12/1977

Vincent Charlon

Corporate Officer/Principal

31/12/1989

31/12/1997

Unni Hjelmaas

Corporate Officer/Principal

31/12/1996

Rolf Schläpfer

Public Communications Contact

31/12/1996

Gerard Farmer

General Counsel

31/12/1988

Pierre Jaccoud

Corporate Secretary

31/12/1987

Eva Losert

Public Communications Contact

Daniel O'Day

Corporate Officer/Principal

Peter Boyle

Investor Relations Contact

Melanie Wolf

Public Communications Contact

Wing-Kai Chan

Corporate Officer/Principal

Ashok Dhanrajgir

Corporate Officer/Principal

Markus Hosang

Corporate Officer/Principal

Simon Roitt

Corporate Officer/Principal

Ivan Melezínek

Corporate Officer/Principal

Tom Edward Pike

Corporate Officer/Principal

Marc Salzberg

Corporate Officer/Principal

Kuno Sommer

Corporate Officer/Principal

Alexander Klauser

Public Communications Contact

07/09/2010

Andreas Greuter

General Counsel

Urs Jaisli

Compliance Officer

30/01/2013

Tim George

Sales & Marketing

Dámaso Molero

Corporate Officer/Principal

Ken A. Brameld

Corporate Officer/Principal

Andreas Emmenegger

Corporate Officer/Principal

Karl Mahler

Investor Relations Contact	-	-
Public Communications Contact	-	-

Peter Johann

Sales & Marketing

Stefan Ryser

Human Resources Officer

Ann Moravick

Corporate Officer/Principal

Robert Salcedo

Corporate Officer/Principal

George Abercrombie

Corporate Officer/Principal

Jean-Pierre Obrecht

Corporate Officer/Principal

Garner William

Corporate Officer/Principal

Fritz Hoffmann-la Roche

Founder

Age distribution of managers

Parity Men Women

Male	19
Female	8

Of which Executive Committee

Male	5
Female	3

Of which Directors

Male	10
Female	1

ESG Refinitiv

A+

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Employees

103,605

Sector

Pharmaceuticals

Calendar

13/09/2024 - European Association for the Study of Diabetes Meeting

Related indices

SMI , STOXX Europe 600 Index (EUR)

More about the company

Departures of Key Persons

Franz Humer

Chairman

05/09/2011 03/03/2014

Fritz Gerber

Chief Executive Officer

- 09/05/2020

Christoph Franz

Chairman

28/02/2014 14/03/2023

Governance Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Executive Committee: Roche Holding AG

Composition of the Board of Directors: Roche Holding AG

Latest Appointments: Roche Holding AG

Former Officers and Directors: Roche Holding AG

Age distribution of managers

Parity Men Women

Environment

Governance

Controversy

Company Profile

Departures of Key Persons

Governance Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Executive Committee: Roche Holding AG

Composition of the Board of Directors: Roche Holding AG

Latest Appointments: Roche Holding AG

Former Officers and Directors: Roche Holding AG

Age distribution of managers

Parity Men Women

Environment

Social

Governance

Controversy

Company Profile

Departures of Key Persons